US Press Releases and News
Navigate within 'US Press Releases and News'
Sandoz US Announces Voluntary Nationwide Recall of two lots of Methotrexate Sodium, USP, Injectable Vials, 25mg/mL, 40mL vials
Princeton, New Jersey, May 20, 2013
Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer. The product is preservative free. The particulates are not associated with microbial contamination. Administration is by physicians/health care professionals.
Sandoz launches diltiazem HCL ER capsules, USP, a generic version of TIAZAC®
Princeton, New Jersey, April 17, 2013
Sandoz today announced the US launch of diltiazem HCL ER capsules, USP, a generic version of Forest Labs’ TIAZAC®.
Sandoz strengthens oral contraceptive portfolio by launching generic versions of Ortho Cyclen® and Ortho Tri-Cyclen®
Princeton, New Jersey, March 19, 2013
Sandoz today announced the US Food and Drug Administration (FDA) approvals and US launches of Estarylla™ (norgestimate and ethinyl estradiol tablets) and Tri-Estarylla™ (norgestimate and ethinyl estradiol tablets), generic equivalents of the oral contraceptives Ortho Cyclen® and Ortho Tri-Cyclen®.
Sandoz calls for US industry collaboration to ensure patient access to critical biologic medicines
Princeton, New Jersey, February 25, 2013
Sandoz has issued a call to action to the US generics industry and other healthcare stakeholders, urging companies to join forces and seize the opportunity to drive patient access to affordable, high-quality biologics, or biosimilars.
Sandoz launches an authorized generic version of argatroban injection (aqueous solution for intravenous infusion)
Princeton, New Jersey, February 19, 2013
Sandoz today announced the US launch of an authorized generic version of Eagle Pharmaceuticals’ ready-to-use argatroban injection 50 mg/50mL, aqueous solution (1 mg/mL).